Correction: Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.
Buccheri S. et al, (2025), Trials, 26
Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.
Buccheri S. et al, (2025), Trials, 26
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
Judge PK. et al, (2024), Nephrol dial transplant
Accelerating Evidence Generation: Addressing Critical Challenges and Charting a Path Forward
Landray M., (2024), Journal of clinical and translational science
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: a post-hoc analysis of the DANFLU-1 randomized clinical trial
Christensen J. et al, (2024), Journal of infection
Overcoming the barriers to better evidence generation from clinical trials
Landray M., (2024), Trials
In practice: RECOVERY Trial
Horby P. et al, (2024), Principles and Practice of Emergency Research Response, 345 - 350
In Practice: RECOVERY Trial
Horby P. et al, (2024), Principles and Practice of Emergency Research Response
Relative Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults with Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial.
Christensen J. et al, (2024), Circ cardiovasc qual outcomes
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
Mayne K. et al, (2024), Nephrology dialysis transplantation
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) for hospitalised patients with COVID-19: prospective meta-analysis of randomised trials
Vale C. et al, (2024), Lancet diabetes & endocrinology
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.
Mayne KJ. et al, (2024), Clin j am soc nephrol
The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
Angus DC. et al, (2024), Jama
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
Lassen MCH. et al, (2024), Diabetes obes metab, 26, 1821 - 1829
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report
Peters AE. et al, (2024), American heart journal